CYTEK BIOSCIENCES, INC. (CTKB) Current Ratio
- Current ratio · latest quarter: Value 4.48×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 4.48× | Current assets / current liabilities. $377.93M ÷ $84.33M ≈ 4.48× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 377.93M USD | Assets, Current |
| Current obligations | 84.33M USD | Liabilities, Current |
| Cash and equivalents | 73.85M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 49.70M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | 52.25M USD | Inventory, Net |
| Payables | (m) | |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $377.93M | $84.33M | $73.85M | (m) | $49.70M | $52.25M | (m) | (m) | 4.48× |
| 2026-03-31 | $379.30M | $80.94M | $65.67M | (m) | $51.90M | $49.79M | (m) | (m) | 4.69× |
| 2025-12-31 | $392.00M | $77.80M | $90.85M | (m) | $62.51M | $48.43M | (m) | (m) | 5.04× |
| 2025-09-30 | $388.49M | $75.21M | $93.28M | (m) | $56.63M | $51.65M | (m) | (m) | 5.17× |
| 2025-06-30 | $382.82M | $73.27M | $75.47M | (m) | $56.23M | $49.49M | (m) | (m) | 5.22× |
| 2025-03-31 | $380.50M | $67.69M | $95.30M | (m) | $55.03M | $45.35M | (m) | (m) | 5.62× |
| 2024-12-31 | $396.45M | $67.66M | $98.72M | (m) | $60.59M | $43.89M | (m) | (m) | 5.86× |
| 2024-09-30 | $390.19M | $62.80M | $162.27M | (m) | $52.63M | $46.80M | (m) | (m) | 6.21× |
| 2024-06-30 | $384.08M | $52.38M | $177.89M | (m) | $44.64M | $50.07M | (m) | (m) | 7.33× |
| 2024-03-31 | $388.65M | $55.57M | $168.79M | (m) | $50.31M | $54.74M | (m) | (m) | 6.99× |
| 2023-12-31 | $392.06M | $56.23M | $167.30M | (m) | $55.93M | $60.88M | (m) | (m) | 6.97× |
| 2023-09-30 | $422.31M | $58.69M | $163.63M | (m) | $55.40M | $66.88M | (m) | (m) | 7.20× |
| 2023-06-30 | $424.82M | $53.59M | $131.54M | (m) | $49.62M | $65.73M | (m) | (m) | 7.93× |
| 2023-03-31 | $425.62M | $56.52M | $129.48M | (m) | $43.10M | $69.50M | (m) | (m) | 7.53× |
| 2022-12-31 | $454.02M | $49.04M | $296.60M | (m) | $48.86M | $48.15M | (m) | (m) | 9.26× |
| 2022-09-30 | $443.86M | $41.49M | $341.52M | (m) | $39.64M | $49.37M | (m) | (m) | 10.70× |
| 2022-06-30 | $443.27M | $42.35M | $349.89M | (m) | $36.81M | $45.34M | (m) | (m) | 10.47× |
| 2022-03-31 | $439.11M | $42.80M | $362.51M | (m) | $30.41M | $37.98M | (m) | (m) | 10.26× |
| 2021-12-31 | $431.73M | $33.18M | $364.62M | (m) | $29.76M | $32.17M | (m) | (m) | 13.01× |
| 2021-09-30 | $439.83M | $30.01M | $376.77M | (m) | $29.45M | $27.51M | (m) | (m) | 14.65× |
| 2021-06-30 | $216.94M | $28.16M | $159.85M | (m) | $24.03M | $26.66M | (m) | (m) | 7.70× |
| 2020-12-31 | $208.62M | $26.54M | $165.23M | (m) | $16.99M | $23.02M | (m) | (m) | 7.86× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |